FilingReader Intelligence
Jubilant Ingrevia reports 29% EBITDA growth in Q1
August 1, 2025 at 05:49 PM UTC•By FilingReader AI
Jubilant Ingrevia reported Q1 revenue of INR 1,038 crore with EBITDA rising 29% year-over-year to INR 153 crore. Profit after tax jumped 54% to INR 75 crore.
The company achieved its highest EBITDA margin in four years at 14.8%, driven by growth in specialty chemicals and nutrition segments.
Specialty chemicals revenue grew 11% with EBITDA surging 52%, maintaining a 27% margin. Chemical intermediates showed recovery with EBITDA increasing 63% quarter-over-quarter to INR 17 crore.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
BSE:JUBLINGREA•Bombay Stock Exchange
News Alerts
Get instant email alerts when Jubilant Ingrevia publishes news
Free account required • Unsubscribe anytime